Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 9/2021

01-09-2021 | Obesity | Original Contributions

The Changes in Body Composition in Obese Patients with Polycystic Ovary Syndrome after Laparoscopic Sleeve Gastrectomy:a 12-Month Follow-up

Authors: Meili Cai, Jingyang Gao, Lei Du, Xiaoyun Cheng, Donglei Zhou, Jiangfan Zhu, Shen Qu, Manna Zhang

Published in: Obesity Surgery | Issue 9/2021

Login to get access

Abstract

Objectives

To investigate the changes in body fat distribution and predicting factors of these changes in polycystic ovary syndrome (PCOS) patients with obesity, after laparoscopic sleeve gastrectomy (LSG).

Methods

This study consecutively enrolled 153 patients with obesity aged 18–45 years (83 with PCOS and 70 control patients) who underwent LSG from May 2013 to September 2020 at the Department of Endocrinology, Shanghai Tenth People’s Hospital, with a 12-month follow-up. Dual-energy X-ray absorptiometry (DEXA) was used to assess body fat distribution.

Results

The percentage of fat mass loss in the visceral adipose tissue (VAT) region (55.08%) was more than that in any other body regions at 12 months post-surgery in the PCOS group yet insignificant. Homeostatic model assessment of insulin resistance (HOMA-IR) at baseline and Δ HOMA-IR were only negatively correlated with the variations in VAT mass and volume at 3 months post-surgery in the PCOS group. Logistic regression analysis showed that HOMA-IR <6.65 was an independent predictive factor for the changes in VAT mass and volume at 3 months post-surgery in the PCOS group.

Conclusions

In this study, the percentage loss of fat mass was greater in the VAT region than in any other body regions in all patients. The rate of VAT decrease in the PCOS group was higher than that in the control group yet insignificant. Compared with control patients, HOMA-IR at baseline was an independent risk factor for the changes in VAT mass and volume at 3 months post-surgery in patients with PCOS.

Key Points

• The percentage loss of fat mass was greater in the VAT region than in any other body regions in all patients.
• The rate of VAT decrease in the PCOS group was higher than that in the control group yet insignificant.
• HOMA-IR at baseline was an independent risk factor for the changes of VAT mass in patients with PCOS.
Appendix
Available only for authorised users
Literature
1.
Azziz R, Carmina E, Chen ZJ, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.CrossRef
2.
Mccartney CR, Solomon CG, Marshall JC. Polycystic ovary syndrome. N Engl J Med. 2016;375(1):54–64.CrossRef
3.
Faloia E, Canibus P, Gatti C, et al. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Investig. 2004;27(5):424–9.CrossRef
4.
Penaforte FRO, Japur CC, Diez-Garcia RW, et al. Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome. J Hum Nutr Diet. 2011;24(1):39–46.CrossRef
5.
Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod. 2001;16(6):1255–60.CrossRef
6.
Escobar-Morreale HF, San Millán JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007;18(7):266–72.CrossRef
7.
Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–84.CrossRef
8.
Abdalla MA, Deshmukh H, Atkin S, et al. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020;11:2042018820938305.CrossRef
9.
Li YJ, Han Y, He B, et al. Effects of bariatric surgery on obese polycystic ovary syndrome: a systematic review and meta-analysis. Surg Obes Relat Dis. 2019;15(6):942–50.CrossRef
10.
Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687–708.CrossRef
11.
Christ JP, Falcone T. Bariatric surgery improves hyperandrogenism, menstrual irregularities, and metabolic dysfunction among women with polycystic ovary syndrome (PCOS). Obes Surg. 2018;28(8):2171–7.CrossRef
12.
Singh D, Arumalla K, Aggarwal S, et al. Impact of bariatric surgery on clinical, biochemical, and hormonal parameters in women with polycystic ovary syndrome (PCOS). Obes Surg. 2020;30(6):2294–300.CrossRef
13.
Dilday J, Derickson M, Kuckelman J, et al. Sleeve gastrectomy for obesity in polycystic ovarian syndrome: a pilot study evaluating weight loss and fertility outcomes. Obes Surg. 2019;29(1):93–8.CrossRef
14.
Benito E, Gómez-Martin JM, Vega-Piñero B, et al. Fertility and pregnancy outcomes in women with polycystic ovary syndrome following bariatric surgery. J Clin Endocrinol Metab. 2020;105(9):439.CrossRef
15.
Tałałaj M, Bogołowska-Stieblich A, Wąsowski M, et al. The influence of laparoscopic sleeve gastrectomy on body composition and fat distribution in obese caucasian men and women. Obes Surg. 2020;30(10):3974–81.CrossRef
16.
Maïmoun L, Lefebvre P, Aouinti S, et al. Acute and longer-term body composition changes after bariatric surgery. Surg Obes Relat Dis. 2019;15(11):1965–73.CrossRef
17.
Tan HC, Khoo CM, Tan MZ, et al. The effects of sleeve gastrectomy and gastric bypass on branched-chain amino acid metabolism 1 year after bariatric surgery. Obes Surg. 2016;26(8):1830–5.CrossRef
18.
Ozeki Y, Masaki T, Yoshida Y, et al. Relationships between computed tomography-assessed density, abdominal fat volume, and glucose metabolism after sleeve gastrectomy in Japanese patients with obesity. Endocr J. 2019;66(7):605–13.CrossRef
19.
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.CrossRef
20.
Yang W, Liu J, Shan Z, et al. Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomized trial. Lancet Diabetes. 2014;2:46–55.CrossRef
21.
Keelan JA, Mattes E, Tan HW, et al. Androgen concentrations in umbilical cord blood and their association with maternal, fetal and obstetric factors. PLoS One. 2012;7(8):e42827.CrossRef
22.
Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, et al. Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study. Diabetes Res Clin Pract. 2011;94(1):146–55.CrossRef
23.
Pazderska A, Tun TK, Phelan N, et al. In women with PCOS, waist circumference is a better surrogate of glucose and lipid metabolism than disease status per se. Clin Endocrinol. 2018;88(4):565–74.CrossRef
24.
Glintborg D, Petersen MH, Ravn P, et al. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls. Acta Obstet Gynecol Scand. 2016;95(11):1235–43.CrossRef
25.
Gökcen BB, Akdevelioğlu Y, Canan S, et al. Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome. Eat Weight Disord. 2020;
26.
Mu LS, Pan JX, Yang LL, et al. Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome. Reprod Biol Endocrinol. 2018;16(1):104.CrossRef
27.
Machado Júnior AS, Ribeiro CBL, Santa-Cruz F, et al. The effect of sleeve gastrectomy on the hormonal profile of patients with polycystic ovary syndrome. Obes Surg. 2019;29(8):2415–9.CrossRef
28.
Kirchengast S, Huber J. Body composition characteristics and fat distribution patterns in young infertile women. Fertil Steril. 2004;81(3):539–44.CrossRef
29.
Douchi T, Ijuin H, Nakamura S, et al. Body fat distribution in women with polycystic ovary syndrome. Obstet Gynecol. 1995;86(4):516–9.CrossRef
30.
Carmina E, Bucchieri S, Esposito A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007;92(7):2500–5.CrossRef
31.
Kim JY, Tfayli H, Michaliszyn SF, et al. Impaired lipolysis, diminished fat oxidation, and metabolic inflexibility in obese girls with polycystic ovary syndrome. J Clin Endocrinol Metab. 2018;103(2):546–54.CrossRef
32.
Ek I, Arner P, Rydén M, et al. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes. 2002;51(2):484–92.CrossRef
33.
Ohira M, Yamaguchi T, Saiki A, et al. Laparoscopic sleeve gastrectomy significantly increases serum lipoprotein lipase level in obese patients. Obes Facts. 2019;12(3):357–68.CrossRef
34.
Bazzocchi A, Ponti F, Cariani S, et al. Visceral fat and body composition changes in a female population after RYGBP: a two-year follow-up by DXA. Obes Surg. 2015;25(3):443–51.CrossRef
35.
Tosi F, Sarra DD, Kaufman JM, et al. Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100(2):661–9.CrossRef
36.
Pasquali R, Casimirri F, Cantobelli S, et al. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Horm Res. 1993;39(5-6):179–87.CrossRef
37.
Echiburú B, Pérez-Bravo F, Galgani JE, et al. Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome. Steroids. 2018;130:15–21.CrossRef
38.
Dumesic DA, Akopians AL, Madrigal VK, et al. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab. 2016;101(11):4178–88.CrossRef
39.
Condorelli RA, Calogero AE, Mauro MD, et al. Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index. J Endocrinol Investig. 2018;41(4):383–8.CrossRef
Metadata
Title
The Changes in Body Composition in Obese Patients with Polycystic Ovary Syndrome after Laparoscopic Sleeve Gastrectomy:a 12-Month Follow-up
Authors
Meili Cai
Jingyang Gao
Lei Du
Xiaoyun Cheng
Donglei Zhou
Jiangfan Zhu
Shen Qu
Manna Zhang
Publication date
01-09-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 9/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05496-6

Other articles of this Issue 9/2021

Obesity Surgery 9/2021 Go to the issue

Original Contributions

Evaluation of Lipoprotein Profile and Residual Risk Three Years After Bariatric Surgery

Review

Comparison Between Laparoscopic Sleeve Gastrectomy and Laparoscopic Greater Curvature Plication Treatments for Obesity: an Updated Systematic Review and Meta-Analysis

Original Contributions

Sleeve Gastrectomy Attenuates the Severity of Cerulein-Induced Acute Pancreatitis in Obese Rats

Original Contributions

Introducing a Bariatric Surgery Program at a Large Urban Safety Net Medical Center Serving a Primarily Hispanic Patient Population

Brief Communication

Early Roux-en-Y Gastrojejunostomy as a Safe and Feasible Treatment of Post Sleeve Gastrectomy Leak

Original Contributions

Comparative Study of Clinical and Ultrasound Parameters for Defining a Difficult Airway in Patients with Obesity